Direct-to-consumer DNA testing company 23andMe has seen its valuation plummet by 99 percent from its $6 billion peak shortly after the company went public in 2021.
What will 23andMe do with the DNA data of 15 million customers?
Read NPR for more.
Related Articles
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
Regeneron to purchase 23andMe, commits to safeguarding customer data
The biotechnology company Regeneron Pharmaceuticals is set to acquire the genetic testing company 23andMe for $256 (£192) million...